Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Anxiety Disorders × nabiximols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Marijuana Abuse 3 Pain 2 Neoplasms 2 Glioblastoma 2 Signs and Symptoms 1 Recurrence 1 Parasomnias 1 Pancreatic Neoplasms 1 Nausea 1 Marijuana Use 1 Cancer Pain 1 Cachexia 1 Brain Neoplasms 1 Anxiety Disorders 1 Anorexia 1 Advanced Malignant Solid Tumor 1 1- Cancer Patients During Chemotherapy Treatment 1

Interventions

Music Therapy 13 Cognitive Behavioral Therapy 11 Therapeutics 9 Psychiatric Rehabilitation 9 Surveys and Questionnaires 8 Standard of Care 8 Methods 8 Educational Status 7 Psilocybin 6 Hypnosis 6 Early Intervention, Educational 6 Mindfulness 5 Control Groups 5 Art Therapy 5 Saline Solution 4 Mindfulness-Based Stress Reduction 4 Mindfulness-Based Cognitive Therapy 4 Ketamine 4 Interviews as Topic 4 Esketamine 4 Behavior Therapy 4 Autogenic Training 4 Aromatherapy 4 Acupuncture Therapy 4 Yoga 3 Weights and Measures 3 Touch 3 Therapeutic Touch 3 Palliative Care 3 Niacin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡